EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | serotonergic antagonist Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonergic agonists. dopamine uptake inhibitor A dopaminergic agent that blocks the transport of dopamine into axon terminals or into storage vesicles within terminals. Most of the adrenergic uptake inhibitors also inhibit dopamine uptake. |
| Applications: | serotonergic antagonist Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonergic agonists. geroprotector Any compound that supports healthy aging, slows the biological aging process, or extends lifespan. anxiolytic drug Anxiolytic drugs are agents that alleviate anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. second generation antipsychotic Antipsychotic drugs which can have different modes of action but which tend to be less likely than first generation antipsychotics to cause extrapyramidal motor control disabilities such as body rigidity or Parkinson's disease-type movements. dopamine uptake inhibitor A dopaminergic agent that blocks the transport of dopamine into axon terminals or into storage vesicles within terminals. Most of the adrenergic uptake inhibitors also inhibit dopamine uptake. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| amperozide (CHEBI:180480) has role anxiolytic drug (CHEBI:35474) |
| amperozide (CHEBI:180480) has role dopamine uptake inhibitor (CHEBI:51039) |
| amperozide (CHEBI:180480) has role geroprotector (CHEBI:176497) |
| amperozide (CHEBI:180480) has role second generation antipsychotic (CHEBI:65191) |
| amperozide (CHEBI:180480) has role serotonergic antagonist (CHEBI:48279) |
| amperozide (CHEBI:180480) is a N-alkylpiperazine (CHEBI:46845) |
| amperozide (CHEBI:180480) is a diarylmethane (CHEBI:51614) |
| amperozide (CHEBI:180480) is a monofluorobenzenes (CHEBI:83575) |
| amperozide (CHEBI:180480) is a secondary carboxamide (CHEBI:140325) |
| amperozide (CHEBI:180480) is a ureas (CHEBI:47857) |
| amperozide (CHEBI:180480) is conjugate base of amperozide(1+) (CHEBI:180484) |
| Incoming Relation(s) |
| amperozide(1+) (CHEBI:180484) is conjugate acid of amperozide (CHEBI:180480) |
| IUPAC Name |
|---|
| 4-[4,4-bis(4-fluorophenyl)butyl]-N-ethylpiperazine-1-carboxamide |
| INNs | Source |
|---|---|
| ampérozide | WHO MedNet |
| amperozide | WHO MedNet |
| amperozida | WHO MedNet |
| amperozidum | WHO MedNet |
| Synonym | Source |
|---|---|
| 4-(4,4-bis(p-fluorophenyl)butyl)-N-ethyl-1-piperazinecarboxamide | ChemIDplus |
| Manual Xrefs | Databases |
|---|---|
| LSM-3159 | LINCS |
| 193 | DrugCentral |
| DB08927 | DrugBank |
| HMDB0248358 | HMDB |
| Amperozide | Wikipedia |
| 66062 | ChemSpider |
| EP0517787 | Patent |
| WO9112805 | Patent |
| Registry Numbers | Sources |
|---|---|
| CAS:75558-90-6 | ChemIDplus |
| Citations |
|---|